Not "If", but "When" and "How": Testing Antibody-Drug Conjugates in Patients with Non-muscle-invasive Bladder Cancer

Eur Urol. 2022 Feb;81(2):143-144. doi: 10.1016/j.eururo.2021.11.008. Epub 2021 Nov 24.

Authors

Moritz J Reike¹, Roy Adar¹, Peter C Black²

Affiliations

¹ Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
² Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. Electronic address: peter.black@ubc.ca.

PMID: 34838351
DOI: 10.1016/j.eururo.2021.11.008

No abstract available

Publication types

Editorial
Comment

MeSH terms

Administration, Intravesical
Cystectomy
Female
Humans
Immunoconjugates* / therapeutic use
Male
Urinary Bladder Neoplasms* / drug therapy
Urinary Bladder Neoplasms* / surgery

Substances

Immunoconjugates